Reduction of Liver X Receptor β expression in primary rat neurons by antisense oligodeoxynucleotides decreases secreted amyloid β levels

Neuroscience Letters

Volumn 561, Issue , 2014, Pages 146-150

  Wang, Qie ^a   Wang, Suling ^b   Shi, Yun ^a   Yao, Min ^a   Hou, Lianguo ^a   Jiang, Lingling ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Province Blood Center   (China)

Author keywords

Alzheimer's disease; Amyloid ; ATP binding cassette transporter; Cholesterol; Liver X Receptor

Indexed keywords

ABC TRANSPORTER A1; ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA SECRETASE 1; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIVER X RECEPTOR BETA; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CHOLESTEROL SYNTHESIS; DOWN REGULATION; GENE EXPRESSION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

ALZHEIMER'S DISEASE; AMYLOID Β; ATP-BINDING CASSETTE TRANSPORTER; CHOLESTEROL; LIVER X RECEPTOR;

ADAM PROTEINS; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANIMALS, NEWBORN; ASPARTIC ACID ENDOPEPTIDASES; ATP BINDING CASSETTE TRANSPORTER 1; CELLS, CULTURED; CHOLESTEROL; DOWN-REGULATION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; NEURONS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; ORPHAN NUCLEAR RECEPTORS; PEPTIDE FRAGMENTS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STEROID HYDROXYLASES;

EID: 84892490841     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.12.055     Document Type: Article

References (27)

1. Murphy M.P., LeVine H. Alzheimer's disease and the amyloid-beta peptide. J. Alzheimers Dis. 2010, 19:311-323. (PubMed: 20061647).
2. Vetrivel K.S., Thinakaran G. Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta 2010, 1801:860-867. (PubMed: 20303415).
3. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5856-5861. (PubMed: 11296263).
4. Di Paolo G., Kim T.W. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 2012, 12:284-296. (PubMed: 21448224).
5. Jakobsson T., Treuter E., Gustafsson J.Å., Steffensen K.R. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol. Sci. 2012, 33:394-404. (PubMed: 22541735).
6. Cavelier C., Lorenzi I., Rohrer L., von Eckardstein A. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim. Biophys. Acta 2006, 1761:655-666. (PubMed: 16798073).
7. Saint-Pol J., Vandenhaute E., Boucau M.C., Candela P., Dehouck L., Cecchelli R., Dehouck M.P., Fenart L., Gosselet F. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation. J. Alzheimers Dis. 2012, 30:489-503. (PubMed: 22433669).
8. Vanmierlo T., Rutten K., Dederen J., Bloks V.W., van Vark-van der Zee L.C., Kuipers F., Kiliaan A., Blokland A., Sijbrands E.J., Steinbusch H., Prickaerts J., Lütjohann D., Mulder M. Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol. Aging 2011, 32:1262-1272. (PubMed: 19674815).
9. Stefulja J., Perica M., Malnar M., Kosicek M., Schweinzer C., Zivkovic J., Scholler M., Panzenboeck U., Hecimovic S. Pharmacological activation of LXRs decreases amyloid-β levels in Niemann-Pick type C model cells. Curr. Pharm. Biotechnol. 2013, [Epub ahead of print].
10. Cui W., Sun Y., Wang Z., Xu C., Xu L., Wang F., Chen Z., Peng Y., Li R. Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels. Neurochem. Res. 2011, 36:1910-1921. (PubMed: 21630010).
11. Sun Y., Yao J., Kim T.W., Tall A.R. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J. Biol. Chem. 2003, 278:27688-27694. (PubMed: 12754201).
12. Zhao C., Dahlman-Wright K. Liver X receptor in cholesterol metabolism. J. Endocrinol. 2010, 204:233-240. (PubMed: 19837721).
13. Andersson S., Gustafsson N., Warner M., Gustafsson J.A. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3857-3862. (PubMed: 15738425).
14. Zelcer N., Khanlou N., Clare R., Jiang Q., Reed-Geaghan E.G., Landreth G.E., Vinters H.V., Tontonoz P. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver X receptors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10601-10606. (PubMed: 17563384).
15. Newton J.R., Parkinson D., Clench M.R. Strategies for examination of Alzheimer's disease amyloid precursor protein isoforms. Anal. Bioanal. Chem. 2006, 385:692-699. (PubMed: 16741768).
16. Pfrieger F.W., Ungerer N. Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 2011, 50:357-371. (PubMed: 21741992).
17. Eckert G.P., Vardanian L., Rebeck G.W., Burns M.P. Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317. Neurosci. Lett. 2007, 423:47-52. (PubMed: 17662526).
18. Whitney K.D., Watson M.A., Collins J.L., Benson W.G., Stone T.M., Numerick M.J., Tippin T.K., Wilson J.G., Winegar D.A., Kliewer S.A. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 2002, 16:1378-1385. (PubMed: 12040022).
19. Terwel D., Steffensen K.R., Verghese P.B., Kummer M.P., Gustafsson J.Å, Holtzman D.M., Heneka M.T. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis. J. Neurosci. 2011, 31:7049-7059. (PubMed: 21562267).
20. Schweinzer C., Kober A., Lang I., Etschmaier K., Scholler M., Kresse A., Sattler W., Panzenboeck U. Processing of endogenous AβPP in blood-brain barrier endothelial cells is modulated by liver-X receptor agonists and altered cellular cholesterol homeostasis. J. Alzheimers Dis. 2011, 27:341-360. (PubMed: 21811018).
21. Vallett S.M., Sanchez H.B., Rosenfeld J.M., Osborne T.F. A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene. J. Biol. Chem. 1996, 271:12247-12253. (PubMed: 8647822).
22. Russell D.W., Halford R.W., Ramirez D.M., Shah R., Kotti T. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu. Rev. Biochem. 2009, 78:1017-1040. (PubMed: 19489738).
23. Lund E.G., Xie C., Kotti T., Turley S.D., Dietschy J.M., Russell D.W. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 2003, 278:22980-22988. (PubMed: 12686551).
24. Tanaka S., Nakamura S., Kimura J., Ueda K. Age-related change in the proportion of amyloid precursor protein mRNAs in the gray matter of cerebral cortex. Neurosci. Lett. 1993, 163:19-21. (PubMed: 8295726).
25. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerriere A., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., Dubas F., Frebourg T., Campion D. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet. 2006, 38:24-26. (PubMed: 16369530).
26. Cirrito J.R., May P.C., O'Dell M.A., Taylor J.W., Parsadanian M., Cramer J.W., Audia J.E., Nissen J.S., Bales K.R., Paul S.M., DeMattos R.B., Holtzman D.M. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J. Neurosci. 2003, 23:8844-8853. (PubMed: 14523085).
27. Garcia-Osta A., Alberini C.M. Amyloid beta mediates memory formation. Learn. Mem. 2009, 16:267-272. (PubMed: 19318468).